For more information about healthcare performance, visit Abbott Diagnostics.
Liver disease is the 5th largest cause of death in the United Kingdom and the only major disease area with an increasing mortality rate for those under 65 years of age. Liver Function Tests (LFTs) are commonly ordered for the assessment and progression of liver disease, of which 20% are abnormal, the causes of which are often complex and often under investigated. Recognizing that the clinical laboratory can play a crucial role in improving prognosis and treatment options, halting disease progression and reducing mortality, an integrated clinical care team from Dundee, Scotland sought to optimize the application and investigation of LFT results.
This webinar presents their innovative best practice in which partners across the clinical care pathway collaborated to develop and implement an Intelligent Liver Function testing (iLFT) algorithm that maximizes detection of early liver disease, increases appropriate investigations and follow-up for patients with abnormal Liver Function Test (LFT) results, and delivers cost-effective high-quality patient care.
What you will learn -
- To understand the importance of liver function testing and to identify gaps in liver disease investigations
- To appreciate the power of health informatics for optimizing liver disease investigations, follow-up, and patient care
- The best practices about how to integrate across healthcare silos to achieve measurable change for patients, clinicians, health systems and payors
Ellie Dow, LRCP, MRCS, PhD, FRCPath
Consultant in Biochemical Medicine, Blood Sciences
John Dillon, MB, BS, MD, FRCP (Edin), FRCP (Lond)
Professor of Hepatology and Gastroenterology,
School of Medicine, University of Dundee